Skip to main content
. 2021 Mar;62(3):319–325. doi: 10.2967/jnumed.120.247411

TABLE 1.

Patient Demographics and Molecular Information

Demographic Data
Total patients 68 (100%)
Female patients 26 (38.2%)
Age ± SD (y) 51.7 ± 14.9
WHO classification grade
 II 29 (42.6%)
 III 25 (36.8%)
 IV 14 (20.6%)
IDH and 1p/19q status
 IDHwt 36 (52.9%)
 IDHm-noncodel 16 (23.5%)
 IDHm-codel 16 (23.5%)
MGMT-promoter methylation status
 Unmethylated 27 (39.7%)
 Methylated 27 (39.7%)
 Unknown 14 (20.6%)
EGFR amplification status
 Negative 38 (55.9%)
 Positive 11 (16.2%)
 Unknown 19 (27.9%)
Surgical procedure
 Biopsy 12 (17.6%)
 Subtotal resection 44 (64.7%)
 Gross total resection 12 (17.6%)

Qualitative data are numbers and percentages; continuous data are mean and SD.